CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

AlphaCore Pharma

AlphaCore Reports Positive Phase 1 Results For New Heart Drug

AlphaCore Pharma announced Tuesday that results from the company’s Phase 1 clinical trial have met the primary endpoint by demonstrating the safety and tolerability of the drug ACP-501 (recombinant human LCAT).

WWJ Newsradio 950–10/09/2012

AlphaCore Pharma art

AlphaCore Pharma Starts Clinical Trial Of New Heart Drug

The biopharmaceutical company AlphaCore Pharma Friday announced it had started a Phase 1 study of its drug candidate, ACP-501, for the treatment of high-risk atherosclerosis and serious lipid metabolism disorders.

WWJ Newsradio 950–04/01/2012

AlphaCore Pharma art

Ann Arbor Firm Part Of Cholesterol Treatment Grant

Ann Arbor-based AlphaCore Pharma and Rockville, Md.-based Advanced Bioscience Laboratories Tuesday announced funding from the National Heart, Lung and Blood Institute, part of the National Institutes of Health, to manufacture a new treatment for a type of coronary artery disease that runs in families.

WWJ Newsradio 950–02/14/2012

Follow

Get every new post delivered to your Inbox.

Join 1,870 other followers